MedPath

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Other: Welltang
Registration Number
NCT02313090
Lead Sponsor
First Affiliated Hospital of Zhejiang University
Brief Summary

The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.

Detailed Description

At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • All diabetes, aged more than 18 years old. No limit for HbA1c was defined
Exclusion Criteria
  • patients have any severe complications such as end phase of diabetic nephropathy or proliferative retinopathy. patients who cannot use smart phone.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
WelltangWelltangpatients using Welltang
Primary Outcome Measures
NameTimeMethod
HbA1c3 months
Secondary Outcome Measures
NameTimeMethod
blood pressure3 months
low density lipoprotein cholesterol3 months
© Copyright 2025. All Rights Reserved by MedPath